Document is current
Any future updates will be listed below
-
Authors
Pardi, Norbert
Hogan, Michael J.
Porter, Frederick W.
Weissman, Drew
- License Information
-
More Information
Article History
First Online: 12 January 2018
Competing interests
: In accordance with the University of Pennsylvania policies and procedures and our ethical obligations as researchers, we report that Norbert Pardi, Michael J. Hogan and Drew Weissman are named on patents that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins and vaccines. We have disclosed those interests fully to the University of Pennsylvania, and we have in place an approved plan for managing any potential conflicts arising from licensing of our patents. Frederick Porter reports no competing financial interests.
Free to read: This content has been made available to all.
